Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning Balance at Dec. 31, 2017 $ 24 $ 243,419 $ (138,043) $ 105,400
Beginning Balance, shares at Dec. 31, 2017 24,275,000
Stock-based compensation $ 105 $ 105
Sale of common stock, net of transaction costs
Sale of common stock, net of transaction costs, shares
Convertible debt instruments
Convertible debt instruments, shares
Exercise of common stock options $ 184 $ 184
Exercise of common stock options, shares 127,000
Net Income (Loss) $ (1,553) $ (1,553)
Ending Balance at Mar. 31, 2018 $ 24 $ 243,708 $ (139,596) $ 104,136
Ending Balance, shares at Mar. 31, 2018 24,402,000
Beginning Balance at Dec. 31, 2017 $ 24 $ 243,419 $ (138,043) $ 105,400
Beginning Balance, shares at Dec. 31, 2017 24,275,000
Net Income (Loss)       $ (2,897)
Ending Balance at Jun. 30, 2018 $ 30 $ 253,556 $ (140,940) $ 112,646
Ending Balance, shares at Jun. 30, 2018 29,923,000
Beginning Balance at Mar. 31, 2018 $ 24 $ 243,708 $ (139,596) $ 104,136
Beginning Balance, shares at Mar. 31, 2018 24,402,000
Stock-based compensation $ 107 $ 107
Sale of common stock, net of transaction costs $ 5 $ 7,679 $ 7,684
Sale of common stock, net of transaction costs, shares 4,435,000
Convertible debt instruments $ 1 $ 2,061 $ 2,062
Convertible debt instruments, shares 1,085,000
Exercise of common stock options $ 1 $ 1
Exercise of common stock options, shares 1,000
Net Income (Loss) $ (1,344) $ (1,343)
Ending Balance at Jun. 30, 2018 $ 30 $ 253,556 $ (140,940) $ 112,646
Ending Balance, shares at Jun. 30, 2018 29,923,000
Beginning Balance at Dec. 31, 2018 $ 30 $ 253,949 $ (187,091) $ 66,888
Beginning Balance, shares at Dec. 31, 2018 29,938,000
Stock-based compensation $ 33 $ 33
Sale of common stock, net of transaction costs $ 2 $ 3,926 $ 3,928
Sale of common stock, net of transaction costs, shares 1,683,000
Convertible debt instruments
Convertible debt instruments, shares
Exercise of common stock options
Exercise of common stock options, shares
Net Income (Loss) $ 2,971 $ 2,971
Ending Balance at Mar. 31, 2019 $ 32 $ 257,908 $ (184,120) $ 73,820
Ending Balance, shares at Mar. 31, 2019 31,621,000
Beginning Balance at Dec. 31, 2018 $ 30 $ 253,949 $ (187,091) $ 66,888
Beginning Balance, shares at Dec. 31, 2018 29,938,000
Net Income (Loss)       $ 1,456
Ending Balance at Jun. 30, 2019 $ 32 $ 258,021 $ (185,635) $ 72,418
Ending Balance, shares at Jun. 30, 2019 31,621,000
Beginning Balance at Mar. 31, 2019 $ 32 $ 257,908 $ (184,120) $ 73,820
Beginning Balance, shares at Mar. 31, 2019 31,621,000
Stock-based compensation $ 113 $ 113
Sale of common stock, net of transaction costs
Sale of common stock, net of transaction costs, shares
Convertible debt instruments
Convertible debt instruments, shares
Exercise of common stock options
Exercise of common stock options, shares
Net Income (Loss) $ (1,515) $ (1,515)
Ending Balance at Jun. 30, 2019 $ 32 $ 258,021 $ (185,635) $ 72,418
Ending Balance, shares at Jun. 30, 2019 31,621,000